Vimta Labs Delivers Steady Q2 FY27 Results With Total Income Up 9.9% YoY
Vimta Labs Ltd · Press Release · 30 Oct 2026, 7:28 pm
Vimta Labs Delivers Steady Q2 FY27 Results With Total Income Up 9.9% YoY Vimta Labs reported Q2 FY27 total income of ₹1,149 Mn, rising 9.9% YoY and 1.8% QoQ, driven by core pharmaceutical and food testing alongside initial revenues from biologics CRAD services. EBITDA grew 10.5% YoY to ₹408 Mn, delivering a 35.5% margin, while PAT rose 3.5% YoY to ₹206 Mn with a 17.9% margin. Basic EPS reached ₹4.6. For H1 FY27, total income increased 11.8% YoY to ₹2,278 Mn and EBITDA advanced 13.2% YoY to ₹819 Mn with a 36.0% margin.
Original exchange filing (PDF)
More announcements from Vimta Labs Ltd
- Transcript of the FY / Q2 - 2026-27 Earnings / Investor Call held on 30th October 2026. · 04 Nov 2026
- Incorporation of a Wholly Owned Subsidiary in the United States of America (USA). · 31 Oct 2026
- Audio Recording of the Earnings Call for Q2 FY 2026-27. · 30 Oct 2026
- Investor Presentation - Q2 Results - FY 2026-27 · 30 Oct 2026
- Vimta Labs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
- Unaudited Financial Results for the 2nd Quarter and Half Year ended 30.09.2026. · 30 Oct 2026
- Unaudited Financial Results for the 2nd Quarter and Half Year ended 30.09.2026. · 30 Oct 2026
- Intimation of Schedule of Analyst/Investor Conference call. · 30 Oct 2026
